Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)
Ginkgo Bioworks Holdings' (DNA) quarterly Change in Working Capital came in at $4.7 million in Q2 2023, up 76.52% on a YoY basis from $2.7 million in Q2 2022, and down 44.5% quarter-over-quarter from $8.5 million in Q1 2023.
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Change in Working Capital for 2 consecutive years, with $4.7 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Change in Working Capital rose 76.52% year-over-year to $4.7 million; the trailing twelve-month figure through Jun 2023 stood at $18.6 million (changed N/A YoY), and the FY2022 full-year result was $10.8 million, changed N/A from the prior year.
- Change in Working Capital declined to $4.7 million in Q2 2023 per DNA's latest filing, from $8.5 million in the prior quarter.
- Across five years, Change in Working Capital topped out at $8.5 million in Q1 2023 and bottomed at $2.7 million in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Working Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 29.74 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 4.73 Mn |
| Mar 31, 2023 | 8.52 Mn |
| Jun 30, 2022 | 2.68 Mn |
| Mar 31, 2022 | 2.65 Mn |